Stocks
Blueprint Medicines Corporation (BPMC) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -535.3% | 38.9% | -348.9% | -252.6% | -190.3% | -55.3% | ||
| Changes by years, y/y, % | -4pp | +574pp | -388pp | +96pp | +62pp | -18.6% | |||
Blueprint Medicines Corporation. EBITDA margin, %
Blueprint Medicines Corporation. EBITDA margin, changes, pp
Blueprint Medicines Corporation (BPMC) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -203.7% | -143.9% | -77.0% | -21.3% | -26.0% | -55.3% | |
| Changes by years, y/y, % | -18pp | +242pp | +118pp | +201pp | +178pp | |||
| Changes by quarters, q/q, % | +19pp | +60pp | +67pp | +56pp | -5pp | |||
